Search
Effective November 16, 2022, New Jersey will impose additional requirements when a ‘health care entity’ is sold or undergoes a change in control. The changes are the result of the enactment of S-315, on August 18, 2021. What You Need to Know: New Jersey enacted a statute that will impose additional...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In a Cannabis Business Times article, Partner Zachary Kobrin in Fort Lauderdale shared predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift in the next year. On the topic of the SAFE Banking Act, Kobrin said it is “the most...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
Saul Ewing is a proud sponsor of the Philadelphia Alliance for Capital and Technologies (PACT) Capital Conference. PACT’s mission is to provide content and connections to capital, coaching, and customers and to collaborate with other organizations to drive innovation and entrepreneurship in the...
Zachary Kobrin spoke on a panel titled, “Mock Negotiation: Buying/Selling A License” at The Marijuana Business Conference (MJBizCon) Cannabis Law Sessions presented by The International Cannabis Bar Association (INCBA). This panel featured a mock negotiation of the purchase/sale of a cannabis...
The No Surprises Act (“NSA”) is a federal law that went into effect January 1, 2022. The NSA statute was enacted as part of the Consolidated Appropriations Act, 2021 and has been implemented by three interim rule s jointly announced by the Office of Personnel Management within the Department of the...
October was National Cybersecurity Month. As part of its ongoing focus on HIPAA Security Rule awareness and compliance, the Office for Civil Rights (“OCR”) within the Department of Health and Human Services (“HHS”), published its HIPAA Security Rule Incident Procedures newsletter (the “Newsletter”)...
This month’s Friday Five covers cases relating to augmentation of the administrative record following new rationales, attempted alternative ERISA causes of action, untimely ERISA claims, plans governed by ERISA even in the absence of a written plan document, and the limited weight given to residual...
Stephanie Denker, an Associate at Saul Ewing, LLP, will be speaking at the ARIAS Fall Conference on November 4, 2022. This session, Rapid Fire Case Presentations, was such a success in years past, it's being brought back for 2022! Hear from five presenters as they compete to convince the audience...
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the 2022 Rowan University Cannabis Forum: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session will cover the implications of cannabis legislation on businesses and...
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the Rowan University Cannabis Forum 2022: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session is entitled "Implications of Cannabis Legislation on Businesses...
Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will speak during the 2022 Tobacco/OTP + CBD Forum in Orlando, FL.
MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...